Q1 2025 Earnings Call Transcript May 5, 2025 Certara, Inc. beats earnings expectations. Reported EPS is $0.14, expectations ...

Fintel reports that on May 8, 2025, Barclays upgraded their outlook for Certara (NasdaqGS:CERT) from Equal-Weight to ...

The projected fair value for Certara is US$8.98 based on 2 Stage Free Cash Flow to Equity Current share price of US$11.37 suggests Certara is potentially 27% overvalued Analyst price target for ...

Certara Inc (CERT) reports a robust 10% revenue growth and unveils strategic advancements, while navigating industry ...

Certara reaffirmed its revenue guidance for 2025, projecting $415 million to $425 million, representing an 8% to 10% growth. Adjusted EBITDA margins are expected to range between 30% and 32%.

Certara, Inc. reports Q1 2025 revenue of $106 million, a 10% increase, with net income of $4.7 million. Certara, Inc. reported strong financial results for the first quarter of fiscal 2025 ...

Certara is well positioned to support the continued adoption of Biosimulation by industry to gain important insights into new therapies. We continue to work closely with our customers as they ...

Q1 2025 Results Conference Call May 5, 2025 5:00 PM ETCompany ParticipantsDavid Deuchler - Investor Relations, Gilmartin ...

Fintel reports that on May 8, 2025, Barclays upgraded their outlook for Certara (NasdaqGS:CERT) from Equal-Weight to Overweight. As of May 6, 2025, the average one-year price target for Certara is ...

Key Insights The projected fair value for Certara is US$8.98 based on 2 Stage Free Cash Flow to Equity Current ...